Xi'an Little White Rabbit Dental Completes New Round of Financing with Investment from Honghui Capital

VCBeat (WeChat: vcbeat) has learned that Xi’an Xiaobaitu Stomatological Medical Co., Ltd. (“Xiaobaitu Dental”) announced today the completion of a new round of financing, with Honghui Capital, an investment firm focused on the healthcare industry, as the investor.

Founded in Ankang, Shaanxi Province, in 2003, Little White Rabbit Dental Care was the first private dental hospital in Shaanxi. In 2009, Little White Rabbit Dental Hospital was established, marking the beginning of its expansion beyond its home region. With pediatric dentistry as its entry point and families as its target clientele, Little White Rabbit Dental Care serves as a family dental provider for everyday consumers, dedicated to making international-standard dental services accessible to the general public.

Currently, Little White Rabbit Dental has established 16 dental hospitals and clinics in Xi’an, Xianyang, Baoji, Ankang, Urumqi, and other cities, deeply cultivating the Northwest China market.

Data shows that Xiaobaitu Dental was listed on the National Equities Exchange and Quotations (NEEQ) on April 26, 2017, becoming the fifth publicly traded company in China’s dental healthcare chain industry. The 2017 annual performance report indicated that the company’s total operating revenue reached RMB 135 million, representing a year-on-year increase of 59.34%. According to the recently released 2018 semi-annual report, the company achieved an operating revenue of RMB 84.99 million, a year-on-year growth of 40.36%.

Regarding this financing round, Mr. Wang Hongying, founder of the Little White Rabbit Dental brand, stated, “We are delighted to partner with a professional investment institution such as Honghui Capital. Following this round of financing, Little White Rabbit Dental will elevate its operations and branding to a new level, becoming a leading dental brand in the central and western regions of China.”

Mr. Wu Jin, Partner at Honghui Capital, an investor in this round, stated, “We are delighted to have reached this cooperation agreement with Chairman Wang Hongying, gaining the opportunity to serve a company like Little White Rabbit Dental, which boasts an excellent customer reputation and strong brand influence. In its development, Little White Rabbit Dental has explored and established operational methods that are well-suited to its unique characteristics and proven effective. We believe that Little White Rabbit Dental will not only provide high-quality medical services to customers but also generate strong synergies with other companies in our investment portfolio.”

About Honghui Capital:

Honghui Capital is an investment fund focused on the healthcare industry, managing dual-currency funds in US dollars and Renminbi, with total assets exceeding RMB 6 billion. Honghui Capital’s investments focus on biopharmaceuticals, medical devices, and related sectors. Its portfolio includes a number of high-quality companies such as Yuwell Medical (002223), WuXi AppTec (603259), Linhua Medical (835637), PharmaBlock (832159), Kintor Pharmaceutical (839419), Mindray Medical, Pharmaron, Baiyang Pharmaceutical, Sansure Biotech, Endovastec, Kangtuo Medical, Malo Clinic, Little White Rabbit Dental, Chaoju Eye Care, and Dr. Cui Yutao Children’s Health Management Center.